HIV-1 Tat and Immune Dysregulation in AIDS Pathogenesis: A Therapeutic Target

被引：11

作者：

Chiozzini, Chiara ^{[1
]}

Toschi, Elena ^{[2
]}

机构：

[1] Ist Super Sanita, Natl AIDS Ctr, I-00161 Rome, Italy

[2] Ist Super Sanita, Dept Hematol Oncol & Mol Med, I-00161 Rome, Italy

来源：

CURRENT DRUG TARGETS | 2016年 / 17卷 / 01期

关键词：

AIDS pathogenesis; immune dysregulation; HIV-1; Tat; therapy; vaccine; HUMAN-IMMUNODEFICIENCY-VIRUS; NF-KAPPA-B; RECEPTOR-RELATED PROTEIN; 2ND CODING EXON; T-CELLS; KAPOSIS-SARCOMA; DENDRITIC CELLS; GROWTH-FACTOR; GENE-THERAPY; IN-VIVO;

D O I：

10.2174/1389450116666150825110658

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The HIV-1 transactivator Tat protein plays a key role in AIDS pathogenesis. Besides the Tat role as activator of HIV-1 transcription, it exerts several important functions on infected and uninfected cells. In fact, HIV-1 Tat is released by infected cells and is taken up by neighboring cells. In this way it regulates expression of viral and cellular genes and it modulates several cellular pathways leading to HIV-1 infection spreading and immune dysregulation. So far, Tat protein and the cellular pathways targeted by Tat may represent potential targets for new anti-HIV therapeutic approaches and vaccine development against AIDS.

引用

页码：33 / 45

页数：13

共 50 条

[21] Tat basic domain: A "Swiss army knife" of HIV-1 Tat? [J].

Kurnaeva, Margarita A. ;

Sheval, Eugene V. ;

Musinova, Yana R. ;

Vassetzky, Yegor S. .

REVIEWS IN MEDICAL VIROLOGY, 2019, 29 (02)

[22] NUCKS1, a novel Tat coactivator, plays a crucial role in HIV-1 replication by increasing Tat-mediated viral transcription on the HIV-1 LTR promoter [J].

Kim, Hye-Young ;

Choi, Byeong-Sun ;

Kim, Sung Soon ;

Roh, Tae-Young ;

Park, Jihwan ;

Yoon, Cheol-Hee .

RETROVIROLOGY, 2014, 11

[23] The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic [J].

Broder, Samuel .

ANTIVIRAL RESEARCH, 2010, 85 (01) :1-18

[24] Immune regulator ABIN1 suppresses HIV-1 transcription by negatively regulating the ubiquitination of Tat [J].

Chen, Shiyou ;

Yang, Xiaodan ;

Cheng, Weijia ;

Ma, Yuhong ;

Shang, Yafang ;

Cao, Liu ;

Chen, Shuliang ;

Chen, Yu ;

Wang, Min ;

Guo, Deyin .

RETROVIROLOGY, 2017, 14

[25] Cellular RelB interacts with the transactivator Tat and enhance HIV-1 expression [J].

Wang, Meng ;

Yang, Wei ;

Chen, Yu ;

Wang, Jian ;

Tan, Juan ;

Qiao, Wentao .

RETROVIROLOGY, 2018, 15 :1-18

[26] The Potential of Immune Modulation in Therapeutic HIV-1 Vaccination [J].

Seddiki, Nabila ;

Picard, Florence ;

Dupaty, Lea ;

Levy, Yves ;

Godot, Veronique .

VACCINES, 2020, 8 (03) :1-13

[27] Is there any room for therapeutic vaccination against the HIV-1/AIDS? [J].

Iglesias, Enrique .

HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2013, 9 (07) :1539-1544

[28] Exosomes: Implications in HIV-1 Pathogenesis [J].

Madison, Marisa N. ;

Okeoma, Chioma M. .

VIRUSES-BASEL, 2015, 7 (07) :4093-4118

[29] Intrinsic Disorder and Function of the HIV-1 Tat Protein [J].

Shojania, Shaheen ;

O'Neil, Joe D. .

PROTEIN AND PEPTIDE LETTERS, 2010, 17 (08) :999-1011

[30] The cross-talk of HIV-1 Tat and methamphetamine in HIV-associated neurocognitive disorders [J].

Mediouni, Sonia ;

Marcondes, Maria Cecilia Garibaldi ;

Miller, Courtney ;

McLaughlin, Jay P. ;

Valente, Susana T. .

FRONTIERS IN MICROBIOLOGY, 2015, 6

← 1 2 3 4 5 →